SITC is pleased to host the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon 2.0 Accelerator: Optimizing combination therapy based on immunological mechanisms.
Accepted applicants into this elite program will participate for free and receive travel reimbursement to SITC Sparkathon Accelerator.
This two-year program will kick off with an in-person retreat June 13-15, 2022, prior to SITC 2022, in New York City. Sparkathon Class of 2022 participants will present their research on this year’s chosen topic of optimizing combination therapy based on immunological mechanisms. Participants will learn from each other and receive guidance from the experts in a synergistic and intimate environment.
In addition to addressing hurdles that mechanisms of resistance pose to the field, SITC’s Sparkathon 2.0 Accelerator explores topics specifically designed for emerging leaders in the cancer immunotherapy field, including:
Participants will spend two-and-a-half days with the top early career investigators and luminaries in the field to advance their work and accelerate the study of optimizing combination therapy based on immunological mechanisms through new knowledge gained, convergent field discussions and long-term cross institutional collaboration. Sparkathon Class of 2022 participants will continue to meet each year at SITC’s Annual Meeting with future Sparkathon Classes, creating a broad network of early career scientists focused on moving the field forward.
Participants must be a SITC student member or regular member in good standing. The Sparkathon target audience is early career physicians and scientists (MD, PhD or MD/PhD) who are in the last few years of their postdoctoral fellowship, medical fellowship, or residency or are junior faculty members (within one year of appointment and do not hold an R01 or equivalent funding) or within the last year obtained a full time position in government, industry, pharma or similar. Applicants must submit an application by 5 p.m. PST on March 2, 2022. Complete applications will consist of: a. cover letter; b. letter of recommendation from outside your home institute; c. recommendation from inside your institute; d. statement of purpose; e. specific aims page OR research summary; f. the applicant’s NIH biosketch; and g. the applicant's CV or resume. Applicants should exhibit dedication and research related to the 2022 Sparkathon 2.0 Accelerator topic, “Optimizing combination therapy based on immunological mechanisms.” Please review the complete application requirements and review criteria for further information.
Apply NowApplications are due 5 p.m. PST on March 2, 2022.Click here for eligibility requirements and application details.
Support the SITC Sparkathon
SITC SPARKATHON 2017 CLASS
SITC SPARKATHON 2018 CLASS
Vaccination and Mask Requirements
At SITC’s Sparkathon 2.0 Accelerator, our goal is to have a safe and meaningful workshop. To help manage the safety of all attending, proof of full vaccination for COVID-19 will be required for all meeting attendees. We are currently assessing solutions for validating vaccination status and that information will be communicated soon.
We are excited and committed to offering a safe, in-person experience, and we will require masks to be worn indoors for onsite attendees. In addition, we will be adhering to the local safety guidelines and regulations. For the latest information on requirements for New York City, click here.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com